HOME >> BIOLOGY >> NEWS
Media Invite: Dinner to award prize for Progress in Cancer Research

The National Foundation for Cancer Research (NFCR) announced a Dinner/Reception to honor Harold F. Dvorak, M.D., Mallinckrodt Professor of Pathology at Harvard Medical School and Chief of the Department of Pathology at Beth Israel Deaconess Medical Center. Dr. Dvorak has been awarded the inaugural Albert Szent-Gyrgyi Prize for Progress in Cancer Research. The Dinner/reception will take place immediately before the American Association for Cancer Research (AACR) annual meeting. All media are invited and encouraged to attend.

ADDITIONAL INFORMATION: The Szent-Gyrgyi Prize Committee selected Dr. Dvorak based on his breakthrough discovery of vascular permeability factor/vascular endothelial cell growth factor (VPF/VEGF) and that contribution that has led to a series of discoveries which both elucidated the mechanisms of angiogenesis as well as the development of antibodies and small molecule therapies to inhibit VEGF.

"Without Dr. Dvorak's fundamental discovery we would probably not have had the therapeutic agent bevacizumab which has had a tremendous impact on improving survival for patients with advanced colorectal cancer, breast cancer, non-cell lung cancer and renal cell carcinoma", stated Chairman of the Szent-Gyrgyi Prize Committee Dr. Daniel Von Hoff, Vice President of the Translational Genomics Research Institute in Phoenix. "In addition, other small molecules which inhibit VEGF have also shown outstanding clinical antitumor activity with dramatic therapeutic effects for patients worldwide."

"Dr. Dvorak's seminal discoveries in basic science have led to significant clinical benefits for cancer patients, perfectly fitting the unique criteria of the Albert Szent-Gyrgyi Prize for Progress in Cancer Research," said Sujuan Ba, Ph.D., NFCR Chief Scientific Officer and Co-Chair of the Szent-Gyrgyi Prize Committee. "Dr. Dvorak's key VPF/VEGF discovery paved the way for researchers to better understand the mechanisms involved in tumor a
'"/>

Contact: Silas Deane
sdeane@nfcr.org
616-319-6007
National Foundation for Cancer Research
31-Mar-2006


Page: 1 2 3 4

Related biology news :

1. Media events planned for 2007 American Society of Gene Therapy meeting, May 30-June 3
2. Porous Media and its Applications in Science, Engineering and Industry
3. Media registration now open for special nanotechnology tour Sept. 12 in San Francisco
4. Media advisory: International mercury conference coming to Madison Aug. 6-11
5. Bat Blitz: Media invited to learn about bats in the southeast
6. Media teleconference announces ocean acidification findings
7. Antarctic Treaty Meeting - Media opportunities
8. Media alert: New study finds dairy is not associated with weight gain
9. 2006 Ocean Sciences Meeting - Media advisory 1
10. Media alert A look forward and a look back: 50 years of crop science
11. Media alert: Special session on the impact of Hurricanes Katrina, Rita on crops, soils, environment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/7/2018)... ... November 07, 2018 , ... ... a senior Clinical Operations professional with extensive experience in clinical trial management, including ... Australia, Latin America, Europe, and Asia, has joined the firm as an Expert ...
(Date:11/7/2018)... ... November 07, 2018 , ... Cognition® Corporation , ... a new white paper discussing Critical-to-Quality (CTQ) Flowup . , The new ... both critical quality requirements and overall product quality. As a bottom-up methodology, CTQ ...
(Date:11/6/2018)... FRANCISCO (PRWEB) , ... November 06, 2018 , ... uBiome, ... of Biochemistry and Biophysics at the University of California, San Francisco (UCSF) and Co-President ... as a scientific adviser to uBiome since 2013, and we are honored that he ...
Breaking Biology News(10 mins):
(Date:11/5/2018)... ... November 05, 2018 , ... 2Blades has completed ... Like (TAL) effector code technology for applications in advancing research in epigenetic technology. ... plants. Since its discovery in 2009, the efficacy of TAL effector-based DNA targeting has ...
(Date:10/31/2018)... ... October 30, 2018 , ... ... controlled trial at the Campbell Clinic in Memphis, Tennessee. This study enrolled ... the standard of care for managing pain after total knee replacement surgery (TKA). ...
(Date:10/29/2018)... (PRWEB) , ... October 29, 2018 , ... PracticeMatch ... employers nationwide, released its schedule of physician career fairs planned for 2019. The company ... will focus hosting live events in the areas of the country which have the ...
(Date:10/24/2018)... ... October 22, 2018 , ... LabRoots, the ... from around the world, will host its first Annual Analytical Chemistry Virtual ... testing, chromatography, centrifugation, as well as developments in chemical sensors & detectors and ...
Breaking Biology Technology:
Cached News: